NUVL.NASDAQNuvalent, INC

Form 4: Nuvalent's Chief Legal Officer Executes Stock Options and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4


Deborah Ann Miller, Chief Legal Officer of Nuvalent, Inc., exercised stock options and sold shares of Class A Common Stock on March 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On March 28, 2024, Deborah Ann Miller, the Chief Legal Officer of Nuvalent, Inc., engaged in transactions involving the company's Class A Common Stock.
  • Miller exercised stock options to acquire 13,000 shares at $18.93 and 9,000 shares at $27.85.
  • Concurrently, Miller sold 2,748 shares at a weighted average price of $74.23, 16,208 shares at $75.22, and 3,044 shares at $75.94.
  • These transactions were executed under a Rule 10b5-1 trading plan adopted on December 27, 2023.
  • Following these transactions, Miller directly owns 33,300 shares of Class A Common Stock.
  • Miller also holds options to purchase 89,000 shares at $18.93 and 102,154 shares at $27.85.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions by an officer under a pre-existing trading plan. There's no inherent positive or negative signal.

Positives

  • The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.

Industry Context

Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors seeking to understand management's perspective on the company's stock.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders as they provide insight into the actions of a key executive.

Key Dates

DateDescription
December 27, 2023Date the reporting person adopted a Rule 10b5-1 trading plan
January 4, 2023Initial vesting date for a portion of the stock options
January 6, 2023Vesting start date for another portion of the stock options
March 28, 2024Date of the reported transactions (exercise of options and sale of shares)
January 4, 2032Expiration date for some of the stock options
January 6, 2033Expiration date for some of the stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.